ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $248 | -99.9% | 4,280 | -20.9% | 0.02% | -10.7% |
Q4 2021 | $250,000 | +3.3% | 5,410 | +30.2% | 0.03% | -22.2% |
Q1 2018 | $242,000 | -49.5% | 4,155 | -44.2% | 0.04% | -57.6% |
Q4 2017 | $479,000 | +128.1% | 7,442 | +65.9% | 0.08% | +112.5% |
Q2 2017 | $210,000 | – | 4,485 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |